Pharmaceutical

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline

The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.

Oct 26, 2024 - 04:00
Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline
The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.
Read the original article

Tags:

Previous Article

GSK pumps up to $800m for US manufacturing site upgrade

Next Article

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The scientist studying how fugitive fetal cells may affect maternal health

The scientist studying how fugitive fetal cells may aff...

Nov 1, 2023

STAT+: Saudi VC loops Novo Nordisk, other biotech VCs into new longevity incubator

STAT+: Saudi VC loops Novo Nordisk, other biotech VCs i...

Nov 29, 2023

STAT+: Federal advisory group rejects proposal to make medical device tracking easier

STAT+: Federal advisory group rejects proposal to make ...

Jun 14, 2023